• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO MEDICAL CORPORATION GLIDESHEATH; INTRODUCER, CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO MEDICAL CORPORATION GLIDESHEATH; INTRODUCER, CATHETER Back to Search Results
Model Number N/A
Medical Device Problem Code Leak/Splash (1354)
Health Effect - Clinical Codes No Consequences Or Impact To Patient (2199); Blood Loss (2597)
Date of Event 07/20/2017
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
The actual device has been returned to the manufacturing facility for evaluation.The investigation is currently ongoing.A follow up report will be submitted once the investigation is complete.For this reason, (b)(4) has been referenced in the conclusions section of evaluation codes.A review of the device history record of the product code/lot# combination was conducted with no relevant findings.A search of the complaint file did find three other reports with the involved product code/lot# combination.The same user facility reported a similar events for another device with the same product code/lot number combination, see mdr 1118880-2017-00054, 1118880-2017-00055, 1118880-2017-00056.All available information has been placed on file in quality assurance at the manufacturing facility for appropriate tracking, trending and follow-up.
 
Event or Problem Description
The user facility reported valve leakage.The following information was provided by the user facility: customer states that the valve is leaking (moderate-severe) more than usual when there is nothing in the valve (wire, catheter, etc.).Used with.035 3 mm j wire.Blood loss was reported to be less than 250 cc.The procedure outcome was successful.It was reported that there was no patient issues.
 
Additional Manufacturer Narrative
This report is being submitted as follow up no.1 to provide the completed investigation results.One used 6fr glidesheath sheaths lot vd29 and dilators were returned evaluation.The components were decontaminated per (b)(4).After decontamination, the sample was subjected to visual analysis where no anomalies were noted.The sheath was returned mated with the dilator.There were no remnants of dried like blood substance present on the device.Functional testing was then performed to identify if a leak would occur on this device per (b)(4).The distal end of the sheath was inserted into a 12 fr balloon.The distal end of the balloon was connected to a controlled air supply system ((b)(4) calibration expiration date: 10/31/2017).The 3-way stopcock (3wsc) was then closed and the air pressure was increased to 4.3 psi (equivalent to 222 mmhg).The sheath with the bub side tubing and 3wsc were all submerged under tap water for approximately 30 seconds.Air bubble formation was seen within 5 seconds of submerging the device.The crosscut valve was then dissected from the hub of the sheath to see if any damage had been sustained to the valve, which may have caused the leakage.There was a discoloration on the bottom side of the valve with evidence of an off center tear in the valve.Upon inspection of the top side of the valve, it was noted that there were no anomalies noted.The manufactured slits on both sides of the device had no anomalies.The complaint could be confirmed for valve leakage since bubble formation was detected around the valve.At this time, the defect observed on the valve appears to have contributed to the leakage.The likely source for the tear in the valve was off center insertion of a component into the valve.The device is inspected for damage to the valve during manufacturing.Therefore, this anomaly would have been caught had it occurred during the manufacturing process.There is no evidence that this event was related to a device defect or malfunction.The exact cause of the reported event cannot be definitively determined based on the available information.All available information has been placed on file in quality assurance at the manufacturing facility for appropriate tracking, trending and follow-up.
 
Additional Manufacturer Narrative
This report is being submitted as follow up no.1 to provide the completed investigation results.It was initially reported that the device was available and the device was returned on august 3, 2017.This date is incorrect.The actual device was not returned for evaluation.No evaluation could be conducted due to the device not being returned.There is no evidence that this event was related to a device defect or malfunction.The exact cause of the reported event cannot be definitively determined based on the available information.All available information has been placed on file in quality assurance at the manufacturing facility for appropriate tracking, trending and follow-up.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GLIDESHEATH
Common Device Name
INTRODUCER, CATHETER
Manufacturer (Section D)
TERUMO MEDICAL CORPORATION
950 elkton blvd.
elkton MD 21921
MDR Report Key6785924
Report Number1118880-2017-00057
Device Sequence Number19102631
Product Code DYB
UDI-Device Identifier00389701011042
UDI-Public00389701011042
Combination Product (Y/N)N
Initial Reporter StateCT
Initial Reporter CountryUS
PMA/510(K) Number
K152173
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source company representative,health
Initial Reporter Occupation Other
Type of Report Initial,Followup,Followup,Followup
Report Date (Section B) 08/10/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date08/31/2019
Device Model NumberN/A
Device Catalogue Number40-1060
Device Lot NumberVD29
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer08/03/2017
Was the Report Sent to FDA? No
Initial Date Received by Manufacturer 07/20/2017
Supplement Date Received by Manufacturer08/25/2017
08/25/2017
09/26/2017
Initial Report FDA Received Date08/10/2017
Supplement Report FDA Received Date09/20/2017
09/20/2017
10/04/2017
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
-
-